Navigation Links
Beckman Coulter, Inc. Announces Pricing of Common Stock Offering
Date:5/20/2009

ORANGE COUNTY, Calif., May 20 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC), a leading developer, manufacturer and marketer of products that simplify, automate and innovate complex biomedical testing, today announced that it priced a public offering of shares of its common stock, the proceeds of which it expects to use to finance in part the previously announced acquisition of the diagnostic systems portion of Olympus Corporation's Life Science business, or the acquisition. Morgan Stanley & Co. Incorporated and Goldman, Sachs & Co. are acting as joint book-running managers for the offering.

(Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO)

In connection with the offering of its common stock, Beckman Coulter is entering into forward sale agreements with each of Morgan Stanley & Co. Incorporated and Goldman, Sachs & Co. or their respective affiliates, whom we refer to as the forward purchasers. The forward purchasers will borrow and sell to the underwriters 4.5 million shares of Beckman Coulter's common stock in connection with the offering. The underwriters are offering these shares to the public at a price of $53.00 per share. The forward sale agreements provide for settlement on a date or dates to be specified by Beckman Coulter at the public offering price less the underwriting discount (subject to adjustment). The settlement of the forward sale agreements is expected to occur in conjunction with the closing of the acquisition, but in no event later than twelve months following the date of the common stock offering. Subject to certain exceptions, Beckman Coulter has the right to elect physical, cash or net share settlement of the forward sale agreements. Assuming physical settlement of the forward sale a
'/>"/>

SOURCE Beckman Coulter, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Beckman Coulter Prices $500 Million Senior Notes Offering
2. Beckman Coulter to Present at the Bank of America and Merrill Lynch Healthcare Conference
3. Beckman Coulter Declares Quarterly Dividend Payout of $0.17 Per Share
4. Beckman Coulter Announces First Quarter 2009 Results
5. Beckman Coulter Announces First Quarter 2009 Earnings to be Released on Tuesday, April 28, 2009, After Market Closes
6. Beckman Coulter to Webcast Annual Stockholders Meeting
7. Beckman Coulter to Acquire Lab-Based Diagnostics Business From Olympus Corporation
8. Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals
9. Beckman Coulter Declares Quarterly Dividend Payout of $0.17 Per Share
10. Beckman Coulter Announces Fourth Quarter 2008 Earnings to be Released on Monday, February 9, 2009, After Market Closes
11. Beckman Coulter to Present at the 27th Annual J.P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... UK (PRWEB) , ... July 27, 2015 , ... Production ... growth over the past few years in the EU. For instance, it surpassed the ... the EUR 92 million mark in 2010. Germany is a major producer, while Italy ...
(Date:7/27/2015)... , July 27, 2015   Inocucor ... produces sustainable biological accelerators for farmers, has received ... and Trademark Office for its patent application to ... accelerate plant growth and enhance yields on farms ... relates to Inocucor,s live IN-M1 microbial consortium and ...
(Date:7/27/2015)... , ... July 27, 2015 , ... ... international sales network Monday. The venture will bring the world’s most efficient gas ... provides state-of-the-art equipment and technologies to both the industrial and municipal markets. With ...
(Date:7/27/2015)... , July 27, 2015 The ... announced the winners of its annual Klerman and ... by scientists who have been supported by NARSAD ... scientists to pursue innovative ideas in neurobiological and ... of concept for the early detection, treatment, prevention ...
Breaking Biology Technology:High Tenacity Filament Yarn of Viscose Rayon Consumption to Grow Swiftly in the EU, Forecasts BAC Reports in New Study Available at MarketPublishers.com 2Inocucor Technologies Receives Groundbreaking U.S. Patent for Proprietary Biological Processes that Stimulate Plant Growth 2Inocucor Technologies Receives Groundbreaking U.S. Patent for Proprietary Biological Processes that Stimulate Plant Growth 3BlueInGreen Brings Water Treatment Technology to Florida 2Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 2Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 3Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 4Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 5Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 6
... Advice Shared Through Dynamic WikiAnswers Q&A ... ... a show of support for National,Breast Cancer Awareness Month, Answers.com,s question ... ), where breast cancer survivors,friends and family have gathered to ask ...
... Win Needed Medical ... Oct. 22 Television medical dramas such as,ER and House ... country to millions of Americans each week. Now, small hospitals,lacking ... - are being given the opportunity to turn the cameras ...
... 22 Genzyme Corp.,(Nasdaq: GENZ ) today ... granted marketing approval for Renvela(TM) (sevelamer carbonate) for,the ... kidney disease on,dialysis. Renvela is a next-generation version ... the United States. "Since its approval in ...
Cached Biology Technology:Answers.com's WikiAnswers Supervisors Rallying for National Breast Cancer Awareness Month 2Answers.com's WikiAnswers Supervisors Rallying for National Breast Cancer Awareness Month 3American M.R.I.-DOL: Small Hospitals To Turn The Camera On Themselves In Unique National Contest 2American M.R.I.-DOL: Small Hospitals To Turn The Camera On Themselves In Unique National Contest 3FDA Approves Genzyme's Renvela(TM) for Dialysis Patients 2FDA Approves Genzyme's Renvela(TM) for Dialysis Patients 3FDA Approves Genzyme's Renvela(TM) for Dialysis Patients 4FDA Approves Genzyme's Renvela(TM) for Dialysis Patients 5
(Date:7/2/2015)... , June 25, 2015 ... the addition of the "Natural Language Processing ... (Recognition, IVR, OCR, Pattern & Image Recognition) - ... offering. The key vendors occupying the ... IBM Corporation, Microsoft Corporation, NetBase Solutions, SAS Institute ...
(Date:6/30/2015)... , June 30, 2015 Genisphere ... company as CEO to help further develop Genisphere,s therapeutics ... of partnering experience, having spent much of the last ... Therakine, Amgen, Baxter Bioscience, and Johnson & Johnson. Tom ... on Technology and Biotech Corporate Finance. He graduated from ...
(Date:6/25/2015)... CITY , June 25, 2015  Imagine a ... steps toward a healthier, happier life. That,s exactly what ... designed to do. The cutting-edge, portable health program provides ... real-life solutions to help improve your lifestyle and nutrition. ... awards dinner and gala Wednesday night, USANA,s THA was ...
Breaking Biology News(10 mins):Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2
... cells communicate with each other and how to enhance ... promising work by a Kansas State University researcher. ... of diagnostic medicine and pathobiology at K-State,s College of ... National Institutes of Health to continue her cancer research. ...
... postmenopausal hormone therapy for more than 15 years increases ... leaner women according to research at the Keck School ... An analysis of the California Teachers Study focused ... women for nearly 10 years. The research was conducted ...
... Georgia Institute of Technology have attained very promising results on ... Using a new technique involving mass spectrometry of a single ... ovarian cancer in 100 percent of the patients tested. The ... Epidemiology, Biomarkers, & Prevention Research . "Because ovarian ...
Cached Biology News:K-State professor's cancer research gets boost from National Institutes of Health 2K-State professor's cancer research gets boost from National Institutes of Health 3Cancer risk found for long-term hormone therapy 2Initial trials on new ovarian cancer tests exhibit extremely high accuracy 2
Goat polyclonal to Ephrin B2 ( Abpromise for all tested applications). entrezGeneID: 1948 SwissProtID: P52799...
... Antibody to ARG. Vasopressin The ... peptide. Cells are found in the ... are found throughout the hypothalmus in ... tissue. Immunogen: ...
Mouse monoclonal [RL13] to LAP1 ( Abpromise for all tested applications). SwissProtID: Q96NW7...
Rabbit polyclonal to LCAT ( Abpromise for all tested applications). entrezGeneID: 3931 SwissProtID: P04180...
Biology Products: